論文

論文紹介

弊社顧問である医学博士　山原篠二先生が執筆者に加わっておられる論文で
弊社商品にかかわる論文のリストをご紹介します。

ショウガに関する論文

  1. Wang C, Batey R, Yamahara J, Li Y (2017). Multiple molecular targets in the liver, adipose tissue and skeletal muscle in ginger-elicited amelioration of nonalcoholic fatty liver disease. Journal of Functional Foods 36, 43-51 (Impact factor: 3.144).
  2. Yang M, Liu C, Jiang J, Zuo G, Lin X, Yamahara J, Wang J, Li Y (2014). Ginger extract diminishes chronic fructose consumption-induced kidney injury through suppression of renal overexpression of proinflammatory cytokines in rats. BMC Complementary and Alternative Medicine 14:174 (Impact factor: 2.080).
  3. Wang J, Gao H, Ke D, Zuo G, Yang Y, Yamahara J, Li Y (2013). Improvement of Liquid Fructose-induced Adipose Tissue Insulin Resistance by Ginger Treatment in Rats Is Associated with Suppression of Adipose Macrophage-related Pro-inflammatory Cytokines. Evidence-Based Complementary and Alternative Medicine. 2013:590376 (Impact factor: 4.774).
  4. Gao H, Guan T, Li C, Zuo G, Yamahara J, Wang J, Li Y (2012). Treatment with ginger ameliorates fructose-induced fatty liver and hypertriglyceridemia in rats: modulation of the hepatic carbohydrate response element binding protein-mediated pathway. Evidence-Based Complementary and Alternative Medicine. 2012:570948 (Impact factor: 4.774).

ウルソ・アップルファイバー関連

  1. Ma P, Yao L, Lin X, Gu T, Rong X, Batey R, Yamahara J, Wang J, Li Y (2016). A mixture of apple pomace and rosemary extract improves fructose consumption-induced insulin resistance in rats: modulation of sarcolemmal
    CD36 and glucose transporter-4. American Journal of Translational Research 2016;8(9):3791-3801 (Impact factor: 2.829).

サラシア関連論文

  1. Wang J, Rong X, Li W, Yamahara J, Li Y (2012). Salacia oblonga ameliorates endogenous hypertriglyceridemia and excessive ectopic fat accumulation in laying hens. Journal of Ethnopharmacology 142:221-227. (Impact factor: 3.014).
  2. He L, Qi Y, Jiang J, Yang Q, Yamahara J, Murray M, Li Y (2011). The Ayurvedic medicine Salacia oblonga attenuates diabetic renal fibrosis in rats: suppression of angiotensin II/AT1 signaling. Evidence-Based Complementary and Alternative Medicine 2011:807451 (Impact factor: 4.774).
  3. Rong X, Kim MS, Su N, Wen S, Matsuo Y, Yamahara J, Murray M, Li Y (2008). An aqueous extract of Salacia oblonga root, a herb-derived peroxisome proliferator-activated receptor-alpha activator, by oral gavage over 28 days induces gender-dependent hepatic hypertrophy in rats. Food and Chemical Toxicology 46:2165-2172. (IF: 2.999).
  4. Li Y, Huang TH, Yamahara J (2008). Salacia root, a unique Ayurvedic medicine, meets multiple targets in diabetes and obesity. Life Sciences 82:1045-1049. (Impact factor: 2.527).
  5. Huang TH, He L, Qin Q, Yang Q, Peng P, Harad M, Qi Y, Yamahara J, Roufogalis BD, Li Y (2008). Salacia oblonga root decreases cardiac hypertrophy in Zucker diabetic fatty rats: inhibition of cardiac expression of angiotensin II type 1 receptor. Diabetes Obesity & Metabolism 10:574-585. (Impact factor: 3.415).
  6. Huang TH, Yang Q, Harada M, Uberai J, Radford J, Li GQ, Yamahara J, Roufogalis BD, Li Y (2006). Salacia oblonga root improves cardiac lipid metabolism in Zucker diabetic fatty rats: Modulation of cardiac PPAR-alpha-mediated transcription of fatty acid metabolic genes. Toxicology and Applied Pharmacology 210:78-85. (Impact factor: 4.447)
  7. Huang TH, Peng P, Li GQ, Yamahara J, Roufogalis BD, Li Y. (2006) Salacia oblonga root improves postprandial hyperlipidemia and hepatic steatosis in Zucker diabetic fatty rats: activation of PPAR-α. Toxicology & Applied Pharmacology 210:225-235. (Impact factor: 4.447).
  8. Li Y, Peng P, GQ, Wen S, Roufogalis BD, Yamahara J (2004). Salacia oblonga improves cardiac fibrosis and inhibits postprandial hyperglycemia in obese Zucker rats. Life Sciences 75:1735-1746. (Impact factor: 2.527)

ザクロ関連論文

  1. Wang J, Rong X, Um ISI, Yamahara J, Li Y (2012). 55-Week treatment of mice with the Unani and Ayurvedic medicine pomegranate flower ameliorates ageing-associated insulin resistance and skin abnormalities. Evidence-Based Complementary and Alternative Medicine 2012:350125 (Impact factor: 4.774).
  2. Xu KZY, Zhu C, Yamahara J, Li Y (2009). Pomegranate flower ameliorates fatty liver in an animal model of type 2 diabetes and obesity: upregulation of hepatic expression of genes responsible for fatty acid oxidation. Journal of Ethnopharmacology 123:280-287 (Impact factor: 3.014).
  3. Li Y, Qi Y, Huang TH., Yamahara J, Roufogalis BD (2008). Pomegranate flower: a unique traditional anti-diabetic medicine with dual PPAR-alpha/gamma activator properties (a review). Diabetes, Obesity & Metabolism 10:10-17. (Impact factor: 3.415).
  4. Huang TH, Yang Q, Harada M, Li GQ, Yamahara J, Roufogalis BD, Li Y. (2005) Pomegranate flower extract diminishes cardiac fibrosis in Zucker diabetic fatty rats: modulation of cardiac endothelin-1 and nuclear factor-kappaB pathways. Journal of Cardiovascular Pharmacology 46:856-862. (IF: 2.406).
  5. Huang TH, Peng G, Kota BP, Li GQ, Yamahara J, Roufogalis BD, Li Y (2005). Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids. British Journal of Pharmacology 145:767-774. (Impact factor: 4.925)
  6. Li Y, Wen S, Kota BP, Peng G, Li GQ, Yamahara J, Roufogalis BD (2005). Punica granatum flower extract, a potent α-glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats. Journal of Ethnopharmacology 99:239-244. (Impact factor: 3.014)
  7. Huang TH, Peng G, Kota BP., Li GQ, Yamahara J, Roufogalis BD, Li Y (2005). Anti-diabetic action of Punica granatum flower extract: activation of PPAR-γ and identification of an active component. Toxicology & Applied Pharmacology 207:160-169. (Impact factor: 4.447)